ArticleProceedings of the National Academy of Sciences of the United States of America2020

Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells.

Xiaolong Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.